Scout | PAR-22-099: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant PAR-22-099

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Summary

This grant supports projects focused on developing advanced biomimetic tissue-engineered technologies for cancer research. It encourages collaboration across fields like regenerative medicine, tissue engineering, and cancer biology to create experimental models that mimic cancer. These projects will be part of the Cancer Tissue Engineering Collaborative (TEC) Research Program, which aims to ad…

This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomater…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Cancer Institute

Program: SBIR

Awards & funding

Award Ceiling: $40,000

Award Amount: $40,000

Dates

Opportunity Released: January 21, 2022

Open for Submission: January 21, 2022

Submission Deadline: May 7, 2025

Application Window Closes: May 7, 2025

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers